JSR Corporation

JSR Corporation engages in the plastics, digital solutions, and life sciences businesses in Japan and internationally. Its Digital Solutions Business provides photoresists and multilayer materials, CMP materials, mounting materials, materials for color LCDs, functional coating materials, heat-resistant transparent resins and functional films, photo fabrication and photo molding systems, etc. for use in semiconductor devices, smartphones, LCD TVs, OLED panel materials, and other materials. The company's Life Sciences Business offers diagnostic and research reagents to purify antibodies and drugs; bio-process materials; drug discovery and development services for biopharmaceutical development process, etc. Its Plastics Business provides synthetic resins, including ABS, AES, AS, and ASA resins for use in automobile parts, household appliances, and building materials. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.

JSR Corporation trades as JSCPF on OTC. The company is classified in Basic Materials / Chemicals - Specialty and reports in USD.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $404.63B of revenue and -$5.55B of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

JSR Corporation can be compared against peers such as Adbri Limited, AGC Inc., HeidelbergCement AG, Holmen AB (publ), Koninklijke DSM N.V., Kumba Iron Ore Limited.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $5.49B, beta of 0.66, and return on equity of -1.5%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

JSCPF currently shows total debt of $179.07B and beta of 0.66. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.jsr.co.jp

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.